Our Services
Medical Information
Helpful Resources
Published on: 9/17/2026
Combining ashwagandha with blood pressure medication may not be safe for everyone, because this adaptogenic herb can lower blood pressure on its own and may amplify the effects of antihypertensive drugs, potentially causing hypotension, dizziness, or fainting. Ashwagandha may also interact with thyroid medications, sedatives, immunosuppressants, and diabetes drugs, and it can affect liver enzymes in rare cases, so timing, dosage, and your specific prescription all matter. Several important factors, including who should avoid it entirely and warning signs that your blood pressure has dropped too low, are explained in the complete answer below. Because supplement interactions depend on your personal health history and current medications, a clinician should confirm what is right for you before you start or stop anything.
If you are noticing lightheadedness, unusual fatigue, a racing heart, or blood pressure readings that seem off, understanding your symptoms early can help you avoid a serious complication, so take a free, instant, online symptom check to see what may be driving how you feel and get clear guidance on your next steps.
Last reviewed for medical accuracy: 09/17/2026
Ashwagandha (Withania somnifera) is a popular adaptogenic herb prized for stress relief, improved energy and potential cardiovascular benefits. Many people wonder about Ashwagandha and heart medication safety—especially if they’re already on blood pressure medicines. Below, we review credible evidence, explain possible interactions and offer practical guidance.
Ashwagandha has been used for centuries in Ayurvedic medicine. Modern studies suggest it may:
Because Ashwagandha can lower stress and possibly relax blood vessels, it may modestly reduce blood pressure. This potential benefit raises questions when you’re already taking antihypertensive (blood pressure) drugs.
Understanding how your medication works helps predict interaction risks. Here are major classes of antihypertensives:
Each class targets blood pressure differently. Adding any supplement that also lowers blood pressure could create additive effects.
Additive Blood Pressure Lowering
Pharmacodynamic Considerations
Individual Variability
Monitor for symptoms of hypotension:
If you notice these, it could indicate your blood pressure is dropping too far.
Before starting any new supplement, the safest approach is to consult your healthcare provider. If you’re considering Ashwagandha alongside your antihypertensive medicine, here are practical steps:
Start Low and Slow
Monitor Blood Pressure Regularly
Watch for Symptoms
Coordinate with Your Healthcare Team
Choose Quality Products
Certain groups may face higher risks when combining Ashwagandha with blood pressure medication:
If any of these apply to you, it’s especially important to discuss Ashwagandha and heart medication safety with your doctor before use.
When used thoughtfully and under medical supervision, Ashwagandha might offer:
Even with careful monitoring, serious reactions can occur. Contact emergency services or go to urgent care if you experience:
These may signal life-threatening complications requiring immediate attention.
If you’re unsure about any new symptom—whether it’s dizziness, rapid heartbeat or persistent fatigue—you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you decide if you need urgent care or can wait to discuss with your regular provider.
Free, online symptom check, using the doctor approved Ubie Symptom Checker
Speak to a doctor about any life-threatening or serious concerns. Your healthcare team can help tailor a safe plan that balances the potential benefits of Ashwagandha with the protection your heart medication provides.
(References)
* LOGES W, NEUWALD F. [Withania root as the falsification of Rauwolfia root]. Arch Pharm Ber Dtsch Pharm Ges. 1956 Sep-Oct;289/61(9-10):604-8. doi: 10.1002/ardp.19562890913. PMID: 13373367.
* Wollen KA. Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Altern Med Rev. 2010 Sep;15(3):223-44. PMID: 21155625.
* Kaur G, Singh N, Samuel SS, Bora HK, Sharma S, Pachauri SD, Dwivedi AK, Siddiqui HH, Hanif K. Withania somnifera shows a protective effect in monocrotaline-induced pulmonary hypertension. Pharm Biol. 2015 Jan;53(1):147-57. doi: 10.3109/13880209.2014.912240. Epub 2014 Sep 19. PMID: 25237891.
* Ahmad H, Khandelwal K, Samuel SS, Tripathi S, Mitra K, Sangwan RS, Shukla R, Dwivedi AK. Neuro-protective potential of a vesicular system of a standardized extract of a new chemotype of Withania somnifera Dunal (NMITLI118RT+) against cerebral stroke in rats(). Drug Deliv. 2016 Sep;23(7):2630-2641. doi: 10.3109/10717544.2015.1041579. Epub 2015 May 28. PMID: 26017242.
* Ahmad H, Arya A, Agrawal S, Samuel SS, Singh SK, Valicherla GR, Sangwan N, Mitra K, Gayen JR, Paliwal S, Shukla R, Dwivedi AK. Phospholipid complexation of NMITLI118RT+: way to a prudent therapeutic approach for beneficial outcomes in ischemic stroke in rats. Drug Deliv. 2016 Nov;23(9):3606-3618. doi: 10.1080/10717544.2016.1212950. Epub 2016 Aug 12. PMID: 27685355.
* Chukwuma CI, Matsabisa MG, Ibrahim MA, Erukainure OL, Chabalala MH, Islam MS. Medicinal plants with concomitant anti-diabetic and anti-hypertensive effects as potential sources of dual acting therapies against diabetes and hypertension: A review. J Ethnopharmacol. 2019 May 10;235:329-360. doi: 10.1016/j.jep.2019.02.024. Epub 2019 Feb 12. PMID: 30769039.
* Saggam A, Limgaokar K, Borse S, Chavan-Gautam P, Dixit S, Tillu G, Patwardhan B. Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management. Front Pharmacol. 2021;12:623795. doi: 10.3389/fphar.2021.623795. Epub 2021 May 3. PMID: 34012390; PMCID: PMC8126694.
* Singh M, Jayant K, Singh D, Bhutani S, Poddar NK, Chaudhary AA, Khan SU, Adnan M, Siddiqui AJ, Hassan MI, Khan FI, Lai D, Khan S. Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy. Front Cell Infect Microbiol. 2022;12:933824. doi: 10.3389/fcimb.2022.933824. Epub 2022 Aug 15. PMID: 36046742; PMCID: PMC9421373.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.